Intracranial vascular stent processing method
By using the pipe and inner mandrel expansion technology matching the intrathecal diameter of the intracranial vascular stent processing, the delivery difficulties and drug loss caused by excessive stent diameter are solved, and the smooth delivery of the stent in the intracranial blood vessels is achieved. and effective treatment.
Patent Information
- Application Number
- CN202111459470.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-02
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-12-02
AI Technical Summary
The external diameter of the existing intracranial vascular stent is too large during processing and delivery, resulting in high friction and difficult to pass through the slender and tortuous intracranial blood vessels. The drug coating is easy to lose, affecting the treatment effect.
Using a compressed state processing bracket with the outer diameter of the pipe material matching the inner diameter of the guide sheath, a bracket parallel to the unit rib rod is made by cutting, and the inner mandrel is expanded and heat-set, ensuring that the bracket is small in the guide sheath and micro-catheter, reducing the outer diameter of the bracket Friction and apply the drug after electrochemical polishing.
The smooth delivery of the stent in the intracranial blood vessels is achieved, reducing the delivery friction and the loss of drug coating, improving the treatment effect, and avoiding the occurrence of embolism events.
Smart Images

Figure CN114224561B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medical devices, in particular to a method for processing an intracranial vascular stent. Background Art
[0002] Stroke refers to an acute cerebral blood circulation disorder caused by stenosis, occlusion or rupture of the cerebral arteries in patients with cerebrovascular disease due to various inducing factors. Clinically, it manifests as symptoms and signs of one-time or permanent brain dysfunction. Stroke or cerebrovascular accident (CVA) causes sudden damage to brain tissue, usually when blood vessels that supply oxygen and other nutrients to the brain burst, or when blood vessels are blocked by blood clots or other particulate matter. If nerve cells lack sufficient oxygen supply, they will die within minutes. Then, the body functions controlled by these nerve cells will also lose their function. Because dead brain cells cannot be replaced, the consequences of stroke are usually permanent.
[0003] The wall structure of the intracranial artery is different from that of blood vessels in other parts of the human body. Its arterial wall has a thick intima layer with a well-developed elastic membrane, while the middle and outer layers are thinner and have no elastic membrane. In addition, the arteries in the cranial cavity are extremely curved. Therefore, the cerebral arteries have almost no pulsation. The intracranial arteries are thin, long, and have a large curvature. They also lack elastic pulsation, so it is not easy to push and remove the emboli that come with the blood, so cerebral embolism is prone to occur. At the same time, the thick intima of the cerebral blood vessels and the lack of pulsation can easily lead to the deposition of lipid substances such as cholesterol and triglycerides, which can harden the blood vessels and cause the intracranial blood vessels to be prone to lumen stenosis.
[0004] The current method for treating intracranial vascular stenosis is to use a balloon-expandable stent, which is designed to pre-install the stent on a balloon and deliver the stent to the site of vascular lesions via a balloon catheter. After the balloon expands to the intended diameter, the stent adheres to the vessel wall by relying on the retraction force of the vessel wall.
[0005] The disadvantages of this method are: since the balloon-expandable stent uses both the balloon and the stent, it has a large outer diameter and poor compliance, and is not easy to pass through the tortuous intracranial blood vessels to reach the lesion.
[0006] Another way to treat intracranial vascular stenosis is to use a self-expanding stent. The self-expanding stent is compressed in a microcatheter and delivered to the site of vascular lesions. The microcatheter is withdrawn to release the self-expanding stent, which then adheres to the blood vessel wall. The self-expanding stent has the advantages of good flexibility, which helps it pass through twisted blood vessels and calcified lesions, can conform to the natural curvature of the blood vessel wall, and is not easily deformed by pressure.
[0007] Whether it is a balloon-expandable stent or a self-expanding stent, the commonly used stent structure includes a unit support body and a unit connecting rod. The unit support bodies are arranged at intervals along the axial direction of the stent. The unit support body is an annular sinusoidal wave structure. The crests and troughs of adjacent unit supports are arranged relatively to each other. Unit connecting rods arranged at intervals along the circumference of the stent are provided between adjacent unit supports. One end of the unit connecting rod is fixedly connected to the crest or trough of one of the unit supports, and the other end is fixedly connected to the trough or crest of another unit support. The unit support body is composed of a unit rib rod and a unit arc head. The unit rib rod is arranged at intervals along the circumference of the stent. The unit arc head is located between adjacent unit rib rods and is at the crest and trough of the sinusoidal wave. The two ends of the unit arc head are respectively connected to the unit rib rods.
[0008] The processing method of the stent in the prior art is: select a tube whose size is slightly smaller than the size of the stent in the expanded state, carve the tube according to the requirements of the drawing, and compress it into the introduction sheath after the carving is completed.
[0009] The shortcomings of this processing method are as follows: first, the size of the tube is slightly smaller than the size of the stent in its expanded state. The tube is compressed after engraving, and the compressed diameter does not match the inner diameter of the introduction sheath. The outer diameter of the compressed stent is too large, and the friction is too large when it is transported in the introduction sheath and the catheter, which is not conducive to pushing in the slender and tortuous blood vessels in the skull, and the drug delivery loss of the stent surface coating is also large; second, the tube engraving process forms a hollow mesh structure, and the stent is in an expanded state after engraving. At this time, there is a large angle between the adjacent unit ribs of the stent. After the stent is processed, the stent needs to be shrunk. This processing method causes a certain angle between the adjacent ribs of the stent after shrinkage (as shown in the attached manual Figure 1-4 As shown in the figure, the outer diameter of the stent in the contracted state is large, and the diameter of the stent delivery device is also correspondingly large, which makes it difficult to pass through the thin and tortuous intracranial arteries and cannot smoothly reach the intracranial lesion site; at the same time, the large diameter of the stent leads to large friction during the delivery process, and the drug delivery loss coated on the surface of the stent is also large. Summary of the invention
[0010] The purpose of the present invention is to solve the deficiencies of the above-mentioned prior art and to provide a method for processing an intracranial vascular stent which has a small outer diameter in a contracted state, is simple in processing, reduces transportation friction, and is suitable for patients with intracranial vascular stenosis.
[0011] The technical solution adopted by the present invention to solve its technical problem is:
[0012] A method for processing an intracranial vascular stent, characterized in that it comprises the following steps:
[0013] Step S1: selecting a tube material for making the compressed stent according to the inner diameter of the introduction sheath, wherein the outer diameter of the tube material matches the inner diameter of the introduction sheath;
[0014] Step S2: cutting and processing the tube to make a stent;
[0015] Step S3: inserting the inner core shaft into the stent along the axial direction of the stent, expanding the stent and heat-setting it;
[0016] Step S4: compressing the expanded stent and loading it into an introduction sheath;
[0017] The outer diameter of the tube selected in this way is the outer diameter of the stent in the compressed state in the introducer sheath and the microcatheter. After the tube is cut and the stent is subsequently expanded and compressed, the stent in the compressed state can still keep the outer diameter matching the inner diameter of the introducer sheath and the microcatheter, making it easier for the stent to move in the introducer sheath and the microcatheter and reducing the friction during delivery.
[0018] In step S2 of the present invention, the stent is made by cutting the tube, and the unit ribs of the stent are arranged in parallel. The unit ribs of the stent made by cutting are arranged in parallel. This state is the compressed state of the stent, which is convenient for cutting and processing, and ensures that under the condition of the same rib width, the overall outer diameter of the stent in the introduction sheath or microcatheter is the smallest, and the outer diameter of the corresponding delivery device can also be reduced to the minimum, so that the stent can easily pass through the thin and tortuous intracranial artery, ensuring that the stent can be smoothly delivered to the lesion site, and at the same time can reduce the friction of the stent during transportation, reduce the loss of the drug coating, and ensure that the drug coating does not fall off during the transportation of the tortuous microcatheter, which not only ensures that there is a sufficient amount of drug to inhibit the proliferation of smooth muscle cells, but also avoids the occurrence of embolic events caused by the shedding of the drug coating, and further ensures the therapeutic effect of intracranial restenosis.
[0019] In step S3 of the present invention, an inner core shaft matching the inner diameter of the stent in its expanded state may be used to expand the stent.
[0020] In step S3 of the present invention, inner core shafts with different diameters may be used to expand the stent step by step.
[0021] The diameter of the inner core shaft of the present invention is 1 mm to 8 mm.
[0022] When the bracket of the present invention is made of metal, the inner core shaft is made of metal; when the bracket is made of non-metallic material, the inner core shaft is made of metal or non-metallic material.
[0023] In step S3 of the present invention, after the stent is expanded and heat-set, the stent is electrochemically polished.
[0024] The width of the unit rib rod of the present invention is 20 μm to 150 μm.
[0025] The surface of the stent of the present invention is coated with a drug coating, and the drug coating comprises a cell inhibitory drug and a drug carrier.
[0026] The cell inhibitory drug of the present invention can be selected from one or more of rapamycin and its derivatives, paclitaxel and its derivatives, heparin, hirudin, prostacyclin, abciximab, dexamethasone, mometasone furoate, and bisphosphonate liposomes; the drug carrier can be selected from one or more of polylactic acid and its derivatives, polylactic acid-glycolic acid, phosphorylcholine, polyvinylidene fluoride hexafluoropropylene copolymer, polyacrylate, lactide and aspartic acid derivative copolymer, polybutyl methacrylate, vinylidene fluoride-hexafluoropropylene, Parylene C, BioLinx polymer, and styrene isobutylene copolymer.
[0027] The beneficial effects of the present invention are as follows: the outer diameter of the tube selected by this processing method is the outer diameter of the stent in the compressed state in the introduction sheath and the microcatheter, and after the tube is cut, the stent is subsequently expanded and then compressed, and the stent in the compressed state can still keep the outer diameter matching the inner diameter of the introduction sheath and the microcatheter, which is convenient for the stent to move in the introduction sheath and the microcatheter and reduce the transportation friction; when cutting the tube, the adjacent unit ribs of the stent are cut into a parallel state according to preset requirements, and the stent is subsequently expanded and then compressed, and the stent in the compressed state can still keep the parallel state of the unit ribs, and under the same rib width conditions, the overall outer diameter of the stent in the compressed state is minimized, which is convenient for moving in the introduction sheath and the microcatheter, and the cutting process is simple and easy to operate. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 It is a schematic diagram of the structure of the prior art stent in a contracted state.
[0029] Figure 2 It is a front view of the structure of the prior art support in a contracted state.
[0030] Figure 3 It is another structural schematic diagram of the prior art stent in the contracted state.
[0031] Figure 4 This is another structural front view of the prior art stent in the contracted state.
[0032] Figure 5 It is a schematic diagram of the structure of the stent in the contracted state of the present invention.
[0033] Figure 6 It is a front view of the structure of the stent in the contracted state of the present invention.
[0034] Figure 7 It is the comparison data of the dimensions of the stent in the contracted state between the present invention and the prior art.
[0035] Figure numerals: unit support body-1, unit rib rod-101, unit arc head-102, unit connecting rod-2. DETAILED DESCRIPTION
[0036] The present invention is described below in conjunction with the accompanying drawings and embodiments.
[0037] As shown in the accompanying drawings, an intracranial vascular stent comprises a unit support 1 and a unit connecting rod 2, wherein the unit support 1 is arranged at intervals along the axial direction of the stent, the unit support 1 is a ring-shaped sinusoidal wave structure, the crests and troughs of adjacent unit support 1 are arranged oppositely, and unit connecting rods 2 arranged at intervals along the circumferential direction of the stent are arranged between adjacent unit support 1, one end of the unit connecting rod 2 is fixedly connected to the crest or trough of one of the unit support 1, and the other end is fixedly connected to the trough or crest of another unit support 1;
[0038] The unit support body 1 is composed of a unit rib 101 and a unit arc head 102. The unit rib 101 is arranged at intervals along the circumference of the bracket. The unit arc head 102 is located between adjacent unit ribs 101 and at the peak and trough of the sine wave. The two ends of the unit arc head 102 are respectively connected to the unit rib 101.
[0039] A method for processing an intracranial vascular stent, characterized in that it comprises the following steps:
[0040] Step S1: selecting a tube material for making the compressed stent according to the inner diameter of the introduction sheath, wherein the outer diameter of the tube material matches the inner diameter of the introduction sheath;
[0041] Step S2: cutting and processing the tube to make a stent;
[0042] Step S3: inserting the inner core shaft into the stent along the axial direction of the stent, expanding the stent and heat-setting it;
[0043] Step S4: compressing the expanded stent and loading it into an introduction sheath;
[0044] The outer diameter of the tube selected in this way is the outer diameter of the stent in the compressed state in the introducer sheath and the microcatheter. After the tube is cut and the stent is subsequently expanded and compressed, the stent in the compressed state can still keep the outer diameter matching the inner diameter of the introducer sheath and the microcatheter, making it easier for the stent to move in the introducer sheath and the microcatheter and reducing the friction during delivery.
[0045] In this embodiment, the outer diameter of the tube can be selected to be smaller than the inner diameter of the introduction sheath, so as to ensure that the stent in a compressed state can be smoothly transferred in the introduction sheath and reduce friction.
[0046] The diameter of the inner core shaft is different, and the outer diameter of the stent in the expanded state is different. Stents with different outer diameters after expansion can be compressed into stents with the same outer diameter and loaded into the introduction sheath, which can minimize the friction resistance of the stent.
[0047] In step S2 of this embodiment, the stent is made by cutting the tube, and the unit ribs of the stent are arranged in parallel. The unit ribs of the stent made by cutting are arranged in parallel. This state is the compressed state of the stent, which is convenient for cutting and processing, and ensures that under the condition of the same rib width, the overall outer diameter of the stent in the introduction sheath or microcatheter is the smallest, and the outer diameter of the corresponding delivery device can also be reduced to the minimum, so that the stent can easily pass through the thin and tortuous intracranial artery, ensuring that the stent can be smoothly delivered to the lesion site, and at the same time can reduce the friction of the stent during transportation, reduce the loss of the drug coating, and ensure that the drug coating does not fall off during the transportation of the tortuous microcatheter, thereby ensuring that there is a sufficient amount of drug to inhibit the proliferation of smooth muscle cells and avoiding the occurrence of embolic events caused by the shedding of the drug coating, further ensuring the treatment effect of intracranial restenosis.
[0048] In step S3 of this embodiment, an inner core shaft matching the inner diameter of the stent in its expanded state may be selected to expand the stent, and the stent may be repeatedly heat treated with the inner core shaft of a fixed diameter to ensure that the stent expansion state is fixed.
[0049] In step S3 of this embodiment, inner core shafts of different diameters may be selected to expand the stent step by step, and inner core shafts with diameters from small to large may be selected, and heat treatment is performed after each insertion and expansion of the inner core shaft.
[0050] A combination of the above two methods may also be adopted, wherein inner core shafts of different diameters are first selected to expand step by step, and then heat treated step by step, and finally an inner core shaft of a fixed diameter is selected to repeat the expansion and heat treatment.
[0051] The diameter of the inner core shaft is 1 mm to 8 mm.
[0052] When the bracket is made of metal, the inner core shaft is made of metal. When the bracket is made of non-metallic material, the inner core shaft is made of metal or non-metallic material.
[0053] The width of the unit rib is 20 μm to 150 μm.
[0054] In this embodiment, the thickness of the tube can be selected according to the supporting force required by the stent.
[0055] In this embodiment, the tube cutting method can be selected from precision processing methods such as laser cutting or wire cutting.
[0056] In step S3 of this embodiment, after the stent is expanded and heat-set, the stent is electrochemically polished. Before the stent is loaded into the introduction sheath after electrochemical polishing, a drug coating is applied on the surface of the stent, and the drug coating includes a cytostatic drug and a drug carrier.
[0057] The cell inhibitory drug can be selected from one or more of rapamycin and its derivatives, paclitaxel and its derivatives, heparin, hirudin, prostacyclin, abciximab, dexamethasone, mometasone furoate, and bisphosphonate liposomes; the drug carrier can be selected from one or more of polylactic acid and its derivatives, polylactic acid-glycolic acid, phosphorylcholine, polyvinylidene fluoride hexafluoropropylene copolymer, polyacrylate, lactide and aspartic acid derivative copolymer, polybutyl methacrylate, vinylidene fluoride-hexafluoropropylene, Parylene C, BioLinx polymer, and styrene isobutylene copolymer.
[0058] Unit development marks are arranged at both ends of the bracket, and the unit development marks are arranged at intervals along the circumference of the bracket.
[0059] In this embodiment, the delivery device for pushing the stent adopts a pushing wire, the diameter of which gradually decreases from the middle to the distal end, so that the tip of the pushing wire is softer, which is convenient for pushing in tortuous blood vessels.
[0060] The distal end of the push wire is wound with a fixed spring coil at intervals along the axial direction of the push wire.
[0061] The spring coil can be made of metal wires such as stainless steel wire, nickel-titanium wire, platinum wire, platinum-iridium wire, etc.
[0062] like Figure 1-Figure 4 As shown, in the prior art, the unit ribs of the bracket are in a non-parallel state when in the contracted state.
[0063] like Figure 5 , Figure 6 As shown, the unit ribs 101 of the stent are arranged in parallel in the contracted state, so that under the same rib width condition, the overall outer diameter of the stent in the introduction sheath or microcatheter is minimized, and the outer diameter of the corresponding delivery device can also be reduced to a minimum.
[0064] In this embodiment, the introduction sheath is used to dock with the microcatheter. When in use, the compressed stent is pushed from the introduction sheath into the microcatheter.
[0065] like Figure 7 As shown, after testing, under the same conditions, the diameter of the bracket in the state where the unit ribs are not parallel is larger than the diameter of the bracket in the state where the unit ribs are parallel.
[0066] When the present invention is used:
[0067] Step S1: The operator inserts an adaptable guide wire and a guide catheter through femoral artery puncture, sends the guide catheter to a suitable position through the guide wire, and withdraws the guide wire;
[0068] Step S2: Use a micro guidewire to carry a micro catheter through the guide catheter to reach the stenotic or occluded blood vessel, and withdraw the micro guidewire;
[0069] Step S3: The operator docks the introduction sheath with the proximal end of the microcatheter, and the push wire pushes the stent from the introduction sheath into the microcatheter, and delivers the stent to the vascular lesion where stenosis or occlusion occurs. During the delivery process of the stent, the unit tendon rods 101 are always in a parallel state;
[0070] Step S4: The operator withdraws the microcatheter and releases the stent, which expands under the action of its own elastic force to open the blood supply pathway of the stenotic or occluded blood vessel;
[0071] Step S5: After the stent is released, the push wire is withdrawn and the stent is implanted into the diseased blood vessel.
Claims
1. A method for processing an intracranial vascular stent, characterized in that: The following steps are involved: Step S1: selecting a tube material for making the compressed stent according to the inner diameter of the introduction sheath, wherein the outer diameter of the tube material matches the inner diameter of the introduction sheath; Step S2: cutting and processing the tube to form a stent, wherein the unit ribs of the stent are arranged in parallel, and this state is the state of compression of the stent. Under the condition of the same rib width, the overall outer diameter of the stent in the introduction sheath is the smallest; Step S3: inserting the inner core shaft into the stent along the axial direction of the stent, expanding the stent and heat-setting the stent; selecting an inner core shaft that matches the inner diameter of the stent in the expanded state to expand the stent, and repeatedly heat-treating the stent with the inner core shaft of a fixed diameter, or selecting inner core shafts with diameters from small to large to expand the stent step by step, and heat-treating the stent after each insertion of the inner core shaft for expansion, or first selecting inner core shafts of different diameters to expand step by step, heat-treating the stent step by step, and finally selecting an inner core shaft of a fixed diameter to repeat the expansion and heat-treating; Step S4: compress the expanded stent and load it into the introduction sheath. After the tube cutting is completed, the stent is subsequently expanded and compressed. The compressed state of the stent keeps the outer diameter matching the inner diameter of the introduction sheath.
2. A method for processing an intracranial vascular stent according to claim 1, characterized in that: The diameter of the inner core shaft is 1 mm to 8 mm.
3. A method for processing an intracranial vascular stent according to claim 1 or 2, characterized in that: When the bracket is made of metal, the inner core shaft is made of metal. When the bracket is made of non-metallic material, the inner core shaft is made of metal or non-metallic material.
4. A method for processing an intracranial vascular stent according to claim 1 or 2, characterized in that: The width of the unit rib is 20 μm to 150 μm.
5. A method for processing an intracranial vascular stent according to claim 1 or 2, characterized in that: In step S3, after the stent is expanded and heat-set, the stent is electrochemically polished.
6. A method for processing an intracranial vascular stent according to claim 5, characterized in that: The surface of the stent is coated with a drug coating, which includes a cell inhibitory drug and a drug carrier.
7. A method for processing an intracranial vascular stent according to claim 6, characterized in that: The cell inhibitory drug is selected from one or more of rapamycin and its derivatives, paclitaxel and its derivatives, heparin, hirudin, prostacyclin, abciximab, dexamethasone, mometasone furoate, and bisphosphonate liposomes; the drug carrier is selected from one or more of polylactic acid and its derivatives, polylactic acid-glycolic acid, phosphorylcholine, polyvinylidene fluoride hexafluoropropylene copolymer, polyacrylate, lactide and aspartic acid derivative copolymer, polybutyl methacrylate, vinylidene fluoride-hexafluoropropylene, Parylene C, BioLinx polymer, and styrene isobutylene copolymer.
